Investor FAQs

Show All
I OWN SHARES OF THE COMPANY’S STOCK – AM I A STOCKHOLDER OF RECORD OR A BENEFICIAL OWNER?

If your shares are registered directly in your name with the Company’s registrar and transfer agent, American Stock Transfer & Trust Company, LLC, you are considered a stockholder of record with respect to those shares. If your shares are held in a brokerage account or bank, trust, or other nominee, you are considered the “beneficial owner” of those shares.

I AM A STOCKHOLDER OF RECORD AND HAVE QUESTIONS ABOUT MY STOCK OWNERSHIP. WHO SHOULD I CONTACT?

If you are a stockholder of record, your record holder account is registered at American Stock Transfer & Trust Company, LLC (“AST”), our registrar and transfer agent.

You may contact AST by phone, by visiting their website or by mail with specific questions about your stock ownership:

Telephone and email assistance:

You may reach an AST representative by dialing (1-800) 937-5449 or by dialing (718) 921-8124. You can also e-mail AST at help@astfinancial.com.

Customer service representatives are available 8 a.m. to 8 p.m. Eastern Time, Monday through Friday.

Mail inquiries:

To contact AST via postal mail:

Caladrius Biosciences, Inc.

c/o AST

6201 15th Avenue

Brooklyn, NY 11219

Be sure to keep your account at AST current. Abandoned property laws in the United States require you to keep your account information current to avoid shares and/or funds from being turned over to the state of your last known residence. Caladrius Biosciences, Inc. is required to follow these abandoned property regulations. Even if you haven’t moved and your statements are delivered quarterly, according to some states, your account could be deemed abandoned if you have not accessed your account or contacted AST within three years.

To avoid your account being deemed abandoned or lost:

Keep your account current. Access your account on-line or vote your proxy. Ensure that AST has your correct address on file. You can change your mailing address at any time by logging on to your online account at https://www.astfinancial.com/. Please note, if you reside outside the U.S., your shares and/or funds would be turned over to Delaware, our state of incorporation.

If your shares are turned over to the state, it will be necessary to contact the state directly and file a claim, which can be a lengthy process.

I AM A BENEFICIAL OWNER AND HAVE QUESTIONS ABOUT MY STOCK OWNERSHIP. WHO SHOULD I CONTACT?

If you are a beneficial owner of shares (e.g., you own shares through a bank or brokerage account) and have specific questions about your stock ownership, it will be necessary to contact your bank/broker directly for assistance.

What does Caladrius do?

Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease. We are developing first-in-class cell therapy products based on the finely tuned mechanisms for self-repair that exist in the human body. Our technology leverages and enables these mechanisms in the form of specific cells, using formulations and modes of delivery unique to each medical indication. To learn more about Caladrius and our CD34+ clinical development programs, please visit the About Us section.

How many employees does Caladrius Biosciences have?
As of December 31, 2020, the company has 24 full-time employees.
Where can I find Caladrius Biosciences’ latest investor presentation?
The most recent investor presentation is available under the Investors & News section.
What is Caladrius’ ticker symbol, exchange and CUSIP?
Exchange: NASDAQ
Ticker Symbol: CLBS
CUSIP: 128058203
What is Caladrius' fiscal year?
Caladrius' fiscal year ends on December 31.
Where are Caladrius Biosciences' headquarters?
110 Allen Road
Second Floor
Basking Ridge, NJ 07920 

Tel: (908) 842-0100
Who is Caladrius’ IR contact?
John D. Menditto
Vice President
Investor Relations & Corporate Communications
Phone: +1-908-842-0084
Email: jmenditto@caladrius.com
 
What is Caladrius’ Financial Conflict of Interest Policy?
You can view the Company’s Financial Conflict of Interest Policy by visiting the Financial Conflict of Interest Policy Statement page.
Who are Caladrius’ auditor and corporate legal counsel?
Caladrius’ auditor is Grant Thornton LLP (www.granthornton.com).

Caladrius’ corporate legal counsel is Mintz Levin Cohn Ferris Glovsky and Popeo PC (www.mintz.com).
Who is Caladrius’ transfer agent?
Caladrius’ transfer agent is American Stock Transfer & Trust Company (AST) (www.astfinancial.com).

Telephone and email assistance
You may reach an AST representative by dialing (1-800) 937-5449 or by dialing (718) 921-8124. You can also e-mail AST at help@astfinancial.com.
Customer service representatives are available 8 a.m. to 8 p.m. Eastern Time, Monday through Friday.

Mail inquiries:
To contact AST via postal mail:
Caladrius Biosciences, Inc.
c/o AST
6201 15th Avenue
Brooklyn, NY 11219
Who do I contact about replacement of stock certificates?
To replace lost stock certificates, please contact Caladrius Biosciences’ transfer agent.
Who should shareholders notify of a change in address?
To change your address, please contact Caladrius Biosciences’ transfer agent.
What financial analysts cover Caladrius Biosciences?
Please refer to the Analyst Coverage section.
Can I buy Caladrius Biosciences stock directly from the company?
Caladrius does not offer a direct stock purchase plan. Shares of the company can be purchased through a brokerage company.
Does Caladrius Biosciences issue dividends on its common stock?
Caladrius Biosciences has never declared or paid cash dividends. The company intends to retain any future earnings for the operation and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future.
When is Caladrius Biosciences’ Annual Meeting of Stockholders?
Specific information about this year’s Annual Shareholder Meeting can be found in this year’s proxy statement available under SEC Filings.
What should I do if I have a question that is not answered here?
Please submit your question using the form under Contact Us.